203 related articles for article (PubMed ID: 16054567)
1. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.
Krüger S; Silber AS; Engel C; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Moeslein G; Dietmaier W; Stemmler S; Friedl W; Rüschoff J; Schackert HK;
Lancet Oncol; 2005 Aug; 6(8):566-72. PubMed ID: 16054567
[TBL] [Abstract][Full Text] [Related]
2. The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1.
Krüger S; Engel C; Bier A; Silber AS; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Royer-Pokora B; Dechant S; Pox C; Rahner N; Müller A; Schackert HK;
Cancer Lett; 2007 Jul; 252(1):55-64. PubMed ID: 17224235
[TBL] [Abstract][Full Text] [Related]
3. The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC).
Krüger S; Bier A; Engel C; Mangold E; Pagenstecher C; von Knebel Doeberitz M; Holinski-Feder E; Moeslein G; Schulmann K; Plaschke J; Rüschoff J; Schackert HK;
J Med Genet; 2005 Oct; 42(10):769-73. PubMed ID: 16199549
[TBL] [Abstract][Full Text] [Related]
4. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.
Daugherty SE; Hayes RB; Yeager M; Andriole GL; Chatterjee N; Huang WY; Isaacs WB; Platz EA
Prostate; 2007 Jun; 67(8):849-54. PubMed ID: 17407163
[TBL] [Abstract][Full Text] [Related]
5. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
Casey G; Neville PJ; Plummer SJ; Xiang Y; Krumroy LM; Klein EA; Catalona WJ; Nupponen N; Carpten JD; Trent JM; Silverman RH; Witte JS
Nat Genet; 2002 Dec; 32(4):581-3. PubMed ID: 12415269
[TBL] [Abstract][Full Text] [Related]
6. RNASEL germline variants are associated with pancreatic cancer.
Bartsch DK; Fendrich V; Slater EP; Sina-Frey M; Rieder H; Greenhalf W; Chaloupka B; Hahn SA; Neoptolemos JP; Kress R
Int J Cancer; 2005 Dec; 117(5):718-22. PubMed ID: 15981205
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the RNASEL gene in familial and sporadic prostate cancer.
Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Am J Hum Genet; 2002 Jul; 71(1):116-23. PubMed ID: 12022038
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
Carpten J; Nupponen N; Isaacs S; Sood R; Robbins C; Xu J; Faruque M; Moses T; Ewing C; Gillanders E; Hu P; Bujnovszky P; Makalowska I; Baffoe-Bonnie A; Faith D; Smith J; Stephan D; Wiley K; Brownstein M; Gildea D; Kelly B; Jenkins R; Hostetter G; Matikainen M; Schleutker J; Klinger K; Connors T; Xiang Y; Wang Z; De Marzo A; Papadopoulos N; Kallioniemi OP; Burk R; Meyers D; Grönberg H; Meltzer P; Silverman R; Bailey-Wilson J; Walsh P; Isaacs W; Trent J
Nat Genet; 2002 Feb; 30(2):181-4. PubMed ID: 11799394
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
[TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC).
Pistorius S; Görgens H; Krüger S; Engel C; Mangold E; Pagenstecher C; Holinski-Feder E; Moeslein G; von Knebel Doeberitz M; Rüschoff J; Karner-Hanusch J; Saeger HD; Schackert HK;
Cancer Lett; 2006 Sep; 241(1):150-7. PubMed ID: 16337339
[TBL] [Abstract][Full Text] [Related]
11. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.
Nakazato H; Suzuki K; Matsui H; Ohtake N; Nakata S; Yamanaka H
Br J Cancer; 2003 Aug; 89(4):691-6. PubMed ID: 12915880
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
13. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
[TBL] [Abstract][Full Text] [Related]
14. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome.
Sotamaa K; Liyanarachchi S; Mecklin JP; Järvinen H; Aaltonen LA; Peltomäki P; de la Chapelle A
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6840-4. PubMed ID: 16203772
[TBL] [Abstract][Full Text] [Related]
15. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.
Wei B; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Yan Z; Xuan F; Zhou H; Huang X; Zhang J; Lu P; Shao J
Mol Biol Rep; 2012 Mar; 39(3):2347-53. PubMed ID: 21656378
[TBL] [Abstract][Full Text] [Related]
16. RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.
Orr-Urtreger A; Bar-Shira A; Bercovich D; Matarasso N; Rozovsky U; Rosner S; Soloviov S; Rennert G; Kadouri L; Hubert A; Rennert H; Matzkin H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):474-9. PubMed ID: 16537704
[TBL] [Abstract][Full Text] [Related]
17. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
Rökman A; Ikonen T; Seppälä EH; Nupponen N; Autio V; Mononen N; Bailey-Wilson J; Trent J; Carpten J; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
Am J Hum Genet; 2002 May; 70(5):1299-304. PubMed ID: 11941539
[TBL] [Abstract][Full Text] [Related]
18. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree.
Ponz de Leon M; Benatti P; Percesepe A; Rossi G; Viel A; Santarosa M; Pedroni M; Roncucci L
Ital J Gastroenterol Hepatol; 1999; 31(6):476-80. PubMed ID: 10575566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
